Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Strom

Showing results (31-40 of 119) with videos related to

Pageof 12
Sort By:
Clinical Breast Cancer|December 17, 2008
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancerAna Maria Gonzalez-Angulo, Ronald Walters, Kristine Broglio, et al.
Cancer|April 8, 2011
Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancerJeffrey M Albert, Ana M Gonzalez-Angulo, Merih Guray, et al.
Cancer|October 25, 2006
African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapyWendy A Woodward, Eugene H Huang, Marsha D McNeese, et al.
Cancer|June 22, 2010
Population-based analysis of occult primary breast cancer with axillary lymph node metastasisGary V Walker, Grace L Smith, George H Perkins, et al.
Cancer|January 19, 2010
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099Ricardo H Alvarez, Daniel J Booser, Massimo Cristofanilli, et al.
CA: a Cancer Journal for Clinicians|October 5, 2002
Standard for breast conservation therapy in the management of invasive breast carcinomaMonica Morrow, Eric A Strom, Lawrence W Bassett, et al.
Cancer|February 11, 2009
The impact of pregnancy on breast cancer outcomes in women<or=35 yearsBeth M Beadle, Wendy A Woodward, Lavinia P Middleton, et al.
CA: a Cancer Journal for Clinicians|October 5, 2002
Standard for the management of ductal carcinoma in situ of the breast (DCIS)Monica Morrow, Eric A Strom, Lawrence W Bassett, et al.
Cancer|January 24, 2008
Risk of hypothyroidism in older breast cancer patients treated with radiationGrace L Smith, Benjamin D Smith, Sharon H Giordano, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index scoreEugene H Huang, Eric A Strom, George H Perkins, et al.
Pageof 12

Showing results (31-40 of 119) with videos related to

Sort By:
Pageof 12
Clinical Breast Cancer|December 17, 2008
Using response to primary chemotherapy to select postoperative therapy: long-term results from a prospective phase II trial in locally advanced primary breast cancerAna Maria Gonzalez-Angulo, Ronald Walters, Kristine Broglio, et al.
Cancer|April 8, 2011
Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancerJeffrey M Albert, Ana M Gonzalez-Angulo, Merih Guray, et al.
Cancer|October 25, 2006
African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapyWendy A Woodward, Eugene H Huang, Marsha D McNeese, et al.
Cancer|June 22, 2010
Population-based analysis of occult primary breast cancer with axillary lymph node metastasisGary V Walker, Grace L Smith, George H Perkins, et al.
Cancer|January 19, 2010
Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : long-term results from the University of Texas M. D. Anderson Cancer Center Study ID97-099Ricardo H Alvarez, Daniel J Booser, Massimo Cristofanilli, et al.
CA: a Cancer Journal for Clinicians|October 5, 2002
Standard for breast conservation therapy in the management of invasive breast carcinomaMonica Morrow, Eric A Strom, Lawrence W Bassett, et al.
Cancer|February 11, 2009
The impact of pregnancy on breast cancer outcomes in women<or=35 yearsBeth M Beadle, Wendy A Woodward, Lavinia P Middleton, et al.
CA: a Cancer Journal for Clinicians|October 5, 2002
Standard for the management of ductal carcinoma in situ of the breast (DCIS)Monica Morrow, Eric A Strom, Lawrence W Bassett, et al.
Cancer|January 24, 2008
Risk of hypothyroidism in older breast cancer patients treated with radiationGrace L Smith, Benjamin D Smith, Sharon H Giordano, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index scoreEugene H Huang, Eric A Strom, George H Perkins, et al.
Pageof 12